OBDUC: The Oxygenation of the Brain During Caesarean Section

Sponsor
Naestved Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01509521
Collaborator
Rigshospitalet, Denmark (Other)
24
1
2
6
4

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the impact of phenylephrine versus ephedrine on organ perfusion, in women undergoing caesarean section receiving spinal anaesthesia. The organ perfusion is estimated by measuring the maternal cerebral oxygenation by NIRS(Near-infrared spectroscopy)and the foetal heartrate.

Condition or Disease Intervention/Treatment Phase
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Oxygenation of the Brain During Caesarean Section. A Comparison of Ephedrine Versus Phenylephrine
Study Start Date :
Feb 1, 2012
Actual Primary Completion Date :
Jul 1, 2012
Actual Study Completion Date :
Aug 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Ephedrine

Drug: Ephedrine
An infusion with a maximum of 3 mg/minute for maximum 60 minutes or if sideeffects develope.
Other Names:
  • Efedrin
  • Ephedrine hydrochloride
  • Active Comparator: Phenylephrine

    Drug: Phenylephrine
    An infusion of maximum 4 mg/hour for maximum 60 minutes.
    Other Names:
  • Phenylephrine Hydrochloride
  • Metaoxedrin
  • Outcome Measures

    Primary Outcome Measures

    1. Frontal lobe cerebral oxygenation [Participants will be followed for the time in the operation theatre of the hospital stay, an expected average of 1 hour]

      Determine the frontal lobe cerebral oxygantion by Near-Infrared Spectroscopy (NIRS),from before induction of spinal anaesthesia to end of surgery.

    2. Foetal heartrate [Participants will be followed for the time in the operation theatre of the hospital stay, an expected average of 1 hour]

      From before induction of spinal anaesthesia to 15 min after delivery

    Secondary Outcome Measures

    1. Mean arterial pressure [Participants will be followed for the time in the operation theatre of the hospital stay, an expected average of 1 hour]

      The mean arterial pressure is measures from before induction of spinal anaesthesia to end of surgery.

    2. Cardiac output [Participants will be followed for the time in the operation theatre of the hospital stay, an expected average of 1 hour]

      The cardiac output is measures from before induction of spinal anaesthesia to end of surgery.

    3. Umbilical cord pH and Base excess [Blood analysis taken immediately after the the clamping of the umbilical cord, an average of 20 minutes.]

      The umbilical cord blood analysis for evaluation of the newborn's acid-base status is taken immediately after delivery. It is the most objective way of assessing the fetal metabolic condition at birth.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Healthy pregnant women

    • Over 18 years old

    • ASA 1-2

    • Undergoing elective caesarean section

    • Height over 160 cm or under 180 cm

    Exclusion Criteria:
    • Allergic reactions to ephedrine or phenylephrine

    • High blood levels of bilirubin

    • HELPP syndrome

    • Preeclampsia (pregnancy-induced hypertension)

    • Non singleton pregnancies

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Naestved Hospital Naestved Denmark 4700

    Sponsors and Collaborators

    • Naestved Hospital
    • Rigshospitalet, Denmark

    Investigators

    • Principal Investigator: Visti Foss, Naestved Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Visti Foss, Principal Investigator, Naestved Hospital
    ClinicalTrials.gov Identifier:
    NCT01509521
    Other Study ID Numbers:
    • 2011-006103-35
    • SJ-271
    First Posted:
    Jan 13, 2012
    Last Update Posted:
    Aug 7, 2012
    Last Verified:
    Aug 1, 2012
    Keywords provided by Visti Foss, Principal Investigator, Naestved Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 7, 2012